Drug class in one race
CCR5 co-receptor drugs for HIV
2 tracked CCR5 co-receptor drugs in the HIV race. The class explanation lives on the CCR5 co-receptor page; the full indication pipeline across every mechanism is on the HIV page.
1 approved / phase 41 Phase 2/3
Head-to-head evidence: Leronlimab vs Maraviroc